INS and metabolic dysfunction-associated steatotic liver disease: In conclusion, our findings suggest that combining DCHD with conventional treatment for NAFLD offers advantages over conventional treatment alone, leading to improved liver function, regulated lipid metabolism, reduced insulin resistance, modulated insulin function, and decreased BMI.